1. A Comment on "Muscle Xenografts Reproduce Key Molecular Features of Facioscapulohumeral Muscular Dystrophy": What Is New and What Has Already been Done and Reported but Was Not Quoted?. (20th July 2020) Authors: Skuk, Daniel; Tremblay, Jacques P Journal: Cell transplantation Issue: Volume 29(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Advances and challenges of using CRISPR-Cas9 gene editing for treating Duchenne muscular dystrophy. Issue 1 (2017) Authors: Ouellet, Dominique L; Duchêne, Benjamin; Iyombe-Engembe, Jean-Paul; Tremblay, Jacques P Journal: Cell & gene therapy insights Issue: Volume 3:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cell therapy in muscular dystrophies: many promises in mice and dogs, few facts in patients. (September 2015) Authors: Skuk, Daniel; Tremblay, Jacques P Journal: Expert opinion on biological therapy Issue: Volume 15:Number 9(2015:Sep.) Page Start: 1307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Development of a therapeutic approach for hereditary diseases with prime editing: A study on Alzheimer's disease. (1st February 2022) Authors: Tremblay, Guillaume; Rousseau, Joël; Happi‐Mbakam, Cedric; Guyon, Antoine; Tremblay, Jacques P Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 3 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Development of a therapeutic approach for hereditary diseases with prime editing: A study on Alzheimer's disease. (December 2021) Authors: Tremblay, Guillaume; Rousseau, Joël; Happi‐Mbakam, Cedric; Guyon, Antoine; Tremblay, Jacques P Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 3 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Human Muscle Precursor Cells Form Human-Derived Myofibers in Skeletal Muscles of Nonhuman Primates: A Potential New Preclinical Setting to Test Myogenic Cells of Human Origin for Cell Therapy of Myopathies. Issue 12 (26th November 2020) Authors: Skuk, Daniel; Tremblay, Jacques P Journal: Journal of neuropathology and experimental neurology Issue: Volume 79:Issue 12(2020) Page Start: 1265 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Insertion of the protective APP A673T mutation by CRISPR/Cas9 base editing or PRIME editing. (17th December 2021) Authors: Tremblay, Jacques P; Guyon, Antoine; Rousseau, Joël; Tremblay, Guillaume; Begin, Francis-Gabriel; Lamothe, Gabriel Journal: Innovation in aging Issue: Volume 5(2021)Supplement 1 Page Start: 669 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Sarcolemmal Complement Membrane Attack Complex Deposits During Acute Rejection of Myofibers in Nonhuman Primates. (July 2018) Authors: Skuk, Daniel; Tremblay, Jacques P Journal: Transplantation Issue: Volume 102(2018)Supplement 7S-1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗